by Patrice D. Cani
Dysosmobacter welbionis is a typical inhabitant of the human gut. New findings suggest it could be a potential next-generation beneficial bacterium for tackling specific cardiometabolic disorders linked to obesity and type 2 diabetes.
by Patrice D. Cani
The gut microbiome is a potential target of interest for scientists in managing obesity and related metabolic diseases. Scientists have isolated a new-bacterium highly prevalent in the human gut and showing benefits for host metabolism.
by GMFH Editing Team
In 2020, we saw important scientific advances in our understanding of how the gut microbiome contributes to human health beyond the gastrointestinal milieu. Discover the year’s breakthroughs in this “2020 Year at a glance” report.
by Patrice D. Cani
Gut microbiota, with its close links to metabolism and the immune system, could potentially be a factor that lies at the core of good health. This means it can be positioned at the heart of the processes that influence the risk of contracting different diseases.
by Andreu Prados
Our gut microbiota profile may help us understand the contribution of bariatric surgery to weight loss. New findings reveal gut microbiota composition before Roux-en-Y gastric bypass is associated with type 2 diabetes remission in obese diabetic women.
by GMFH Editing Team
Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.
by GMFH Editing Team
Ruling out the specific contribution of obesity and type 2 diabetes in gut microbiome variation is a challenge. Louise Thingholm and colleagues have found that while obesity is linked to gut microbiome variation, gut microbiome associations with type 2 diabetes are modest.
by Andreu Prados
The second phase of the Human Microbiome Project has recently been completed. Multi-omics of the gut microbial ecosystem has allowed for the discovery of new host-microbiome interactions that could help in precision medicine in those with IBDs and prediabetes.
by GMFH Editing Team
The gut microbiota may interfere with our energy metabolism at different levels. New findings in mice provide evidence of the impact of gut microbiota on brown adipose tissue and white adipose tissue beiging, opening a potential target for obesity management.
by Andreu Prados
A decrease in the levels of butyrate-producing gut bacteria has been found in patients with high cardiovascular risk. In mice, bacterial butyrate can prevent atherosclerosis by increasing gut barrier function secondary to the upregulation of tight junction genes.
